Development of a Universal Influenza Vaccine.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 30 07 2018
accepted: 30 08 2018
entrez: 9 1 2019
pubmed: 9 1 2019
medline: 29 10 2019
Statut: ppublish

Résumé

The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our current seasonal influenza vaccine. Thus, the National Institute of Allergy and Infectious Diseases recently announced a strategic plan to improve current influenza vaccines and eventually develop a "universal" influenza vaccine. This review will highlight the many different strategies being undertaken in pursuit of this goal and the exciting advances made by the influenza community. There is no doubt that an improved influenza vaccine is on the horizon.

Identifiants

pubmed: 30617121
pii: 202/2/392
doi: 10.4049/jimmunol.1801054
pmc: PMC6327971
mid: NIHMS1506719
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

392-398

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201400006C
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI106700
Pays : United States

Informations de copyright

Copyright © 2019 by The American Association of Immunologists, Inc.

Références

Ther Adv Vaccines. 2015 Jul;3(4):97-108
pubmed: 26478817
PLoS One. 2014 Mar 25;9(3):e92153
pubmed: 24667168
J Infect Dis. 2018 Jul 2;218(3):347-354
pubmed: 29506129
Nature. 2008 Jan 31;451(7178):591-5
pubmed: 18235503
J Gen Virol. 1993 Jan;74 ( Pt 1):143-6
pubmed: 8423445
Emerg Infect Dis. 2006 Apr;12(4):569-74
pubmed: 16704803
J Immunol. 2007 Jan 15;178(2):1030-8
pubmed: 17202366
J Virol Methods. 2014 Dec 15;210:7-14
pubmed: 25233882
J Virol. 2006 Dec;80(23):11756-66
pubmed: 16971435
Vaccines (Basel). 2018 May 21;6(2):
pubmed: 29883414
Obesity (Silver Spring). 2013 Nov;21(11):2377-86
pubmed: 23512822
Vaccine. 2009 Nov 5;27(47):6512-21
pubmed: 19729082
J Immunol. 2013 Feb 15;190(4):1837-48
pubmed: 23319732
Virology. 2003 Feb 1;306(1):18-24
pubmed: 12620793
Expert Rev Vaccines. 2017 Feb;16(2):123-136
pubmed: 27653543
J Infect Dis. 2011 Sep 15;204(6):845-53
pubmed: 21846636
Am J Respir Crit Care Med. 2015 Jun 15;191(12):1422-31
pubmed: 25844934
Clin Infect Dis. 2012 Jul;55(1):19-25
pubmed: 22441650
J Immunol. 2004 May 1;172(9):5598-605
pubmed: 15100303
Microbes Infect. 2008 Jul;10(9):1024-9
pubmed: 18662798
Nat Med. 2012 Jan 29;18(2):274-80
pubmed: 22286307
Arch Virol. 1993;130(1-2):45-56
pubmed: 7684894
Proc Natl Acad Sci U S A. 1990 Jan;87(2):786-90
pubmed: 2300562
mBio. 2017 Mar 21;8(2):
pubmed: 28325769
Vaccine. 2017 Dec 4;35(48 Pt B):6691-6699
pubmed: 29079099
J Virol. 2005 Sep;79(17):11014-21
pubmed: 16103152
J Cell Biol. 1996 May;133(4):733-47
pubmed: 8666660
J Exp Med. 2011 Jan 17;208(1):181-93
pubmed: 21220454
Vaccine. 2005 Nov 16;23(46-47):5404-10
pubmed: 16011865
J Infect Dis. 2015 Oct 15;212(8):1191-9
pubmed: 25858957
Eur J Immunol. 2008 Jan;38(1):114-26
pubmed: 18081037
PLoS One. 2010 Oct 04;5(10):e13162
pubmed: 20976273
Clin Microbiol Infect. 2017 Apr;23(4):222-228
pubmed: 28216325
Nat Rev Microbiol. 2018 Jan;16(1):47-60
pubmed: 29081496
Virology. 1987 Feb;156(2):386-95
pubmed: 3811239
J Clin Microbiol. 1986 Jul;24(1):157-60
pubmed: 3722363
Science. 2010 Apr 16;328(5976):357-60
pubmed: 20339031
Biotechnol J. 2015 May;10(5):690-701
pubmed: 25728134
J Virol. 2013 Jun;87(12):6542-50
pubmed: 23576508
Clin Microbiol Rev. 2013 Jul;26(3):476-92
pubmed: 23824369
Nat Med. 2014 Feb;20(2):143-51
pubmed: 24412922
Influenza Other Respir Viruses. 2008 Nov;2(6):211-9
pubmed: 19453397
mBio. 2018 Jan 23;9(1):
pubmed: 29362240
Am J Respir Crit Care Med. 2012 Dec 15;186(12):1292-7
pubmed: 23087026
Curr Opin Virol. 2013 Oct;3(5):521-30
pubmed: 23978327
Crit Rev Immunol. 2014;34(1):15-39
pubmed: 24579700
N Engl J Med. 1972 Jun 22;286(25):1329-32
pubmed: 5027388
Vaccine. 2010 Feb 25;28(9):2076-9
pubmed: 20044052
Clin Infect Dis. 2011 Jan 1;52(1):1-7
pubmed: 21148512
Curr Opin Immunol. 2018 Aug;53:96-101
pubmed: 29730560
J Immunol. 2011 Jan 15;186(2):1022-31
pubmed: 21169548
mBio. 2010 May 18;1(1):
pubmed: 20689752
Virology. 1989 Jul;171(1):275-9
pubmed: 2741346
PLoS Pathog. 2010 Feb 26;6(2):e1000796
pubmed: 20195520
Nat Med. 2013 Oct;19(10):1305-12
pubmed: 24056771
Nat Commun. 2015 May 13;6:6833
pubmed: 25967273
J Virol. 2005 Jun;79(11):6644-54
pubmed: 15890902
J Infect Dis. 2015 May 15;211(10):1541-9
pubmed: 25425696
N Engl J Med. 2007 Feb 15;356(7):685-96
pubmed: 17301299
Antiviral Res. 2008 Nov;80(2):168-77
pubmed: 18598723
Vaccine. 2008 Jun 25;26(27-28):3395-403
pubmed: 18511159
J Immunol. 2017 Jun 15;198(12):4738-4752
pubmed: 28500069
N Engl J Med. 1983 Jul 7;309(1):13-7
pubmed: 6602294
J Infect Dis. 2013 Mar 15;207(6):974-81
pubmed: 23307936
PLoS One. 2015 Aug 17;10(8):e0135474
pubmed: 26280677
PLoS One. 2015 Apr 27;10(4):e0124677
pubmed: 25915748
PLoS One. 2012;7(10):e48322
pubmed: 23118984
Eur J Immunol. 2013 Jul;43(7):1940-52
pubmed: 23589155
Curr Opin Immunol. 2018 Aug;53:38-44
pubmed: 29674167
Nat Med. 2015 Sep;21(9):1065-70
pubmed: 26301691
Vaccines (Basel). 2018 Jul 25;6(3):
pubmed: 30044403
Nat Rev Drug Discov. 2015 Mar;14(3):167-82
pubmed: 25722244
Sci Immunol. 2017 Jun 2;2(12):
pubmed: 28783656
PLoS One. 2013;8(3):e55435
pubmed: 23536756
Front Immunol. 2018 Jul 02;9:1479
pubmed: 30013557
PLoS One. 2011;6(10):e25797
pubmed: 22039424
mBio. 2016 Apr 19;7(2):e00417-16
pubmed: 27094330
Sci Rep. 2013;3:1443
pubmed: 23485942
Eur J Pharm Biopharm. 2015 Aug;94:251-63
pubmed: 26047796
J Virol. 2008 Oct;82(20):10059-70
pubmed: 18701586
J Virol. 2012 May;86(10):5774-81
pubmed: 22398287
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):246-51
pubmed: 17200302
J Virol. 2013 Apr;87(8):4728-37
pubmed: 23408625
Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):
pubmed: 28663209
Nat Med. 1999 Oct;5(10):1157-63
pubmed: 10502819
Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20748-53
pubmed: 22143798
Science. 2015 Sep 18;349(6254):1301-6
pubmed: 26303961
MMWR Morb Mortal Wkly Rep. 2018 Jun 08;67(22):643-645
pubmed: 29879095
Front Immunol. 2016 Feb 05;7:25
pubmed: 26904022
Arch Virol. 2007;152(6):1047-59
pubmed: 17516034
Viruses. 2017 Sep 21;9(10):
pubmed: 28934167
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12658-63
pubmed: 20615945
J Clin Invest. 1998 Nov 1;102(9):1653-61
pubmed: 9802879
Virology. 2017 Jan;500:178-183
pubmed: 27825034
mBio. 2016 Aug 02;7(4):
pubmed: 27486196
Curr Opin Virol. 2017 Feb;22:105-111
pubmed: 28088686
Virus Res. 1992 Mar;22(3):247-58
pubmed: 1626420
J Exp Med. 2013 Jul 29;210(8):1493-500
pubmed: 23857983
J Pharm Sci. 2006 Jan;95(1):70-9
pubmed: 16315228
Am J Epidemiol. 2018 Dec 1;187(12):2603-2614
pubmed: 30084906
Virology. 2002 Oct 25;302(2):294-8
pubmed: 12441073
Vaccine. 2010 Jan 8;28(3):790-7
pubmed: 19887135
Lancet Infect Dis. 2018 Jan;18(1):e25-e32
pubmed: 28780285
Mol Ther. 2014 Jan;22(1):233-8
pubmed: 23831594
J Immunol. 2009 Mar 1;182(5):3063-71
pubmed: 19234203
Vaccine. 2018 Jul 5;36(29):4198-4206
pubmed: 29887326
MMWR Morb Mortal Wkly Rep. 2018 Jun 08;67(22):634-642
pubmed: 29879098
J Immunol. 2008 Sep 15;181(6):4168-76
pubmed: 18768874
Vaccine. 2016 Jan 20;34(4):458-465
pubmed: 26707221
Expert Rev Vaccines. 2009 Apr;8(4):499-508
pubmed: 19348565

Auteurs

Leonardo D Estrada (LD)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105.

Stacey Schultz-Cherry (S)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105 Stacey.schultz-cherry@stjude.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH